Loading...
Loading...
Incyte
INCY touched a new 52-week high of $33.90 on positive top-line results of Phase II proof-of-concept trial of ruxolitinib.
Core-Mark Holding Company
CORE shares reached a new 52-week high of $67.95. Core-Mark's PEG ratio is 1.16.
Citi Trends
CTRN shares jumped 13.48% to touch a new 52-week high of $16.58 after the company reported Q2 results.
TASER International
TASR shares created a new 52-week high of $11.20. TASER shares have jumped 100.55% over the past 52 weeks, while the S&P 500 index has gained 16.90% in the same period.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in